Mobia Medical (NASDAQ:MOBI) Upgraded at The Goldman Sachs Group

Mobia Medical (NASDAQ:MOBI) was upgraded by equities researchers at The Goldman Sachs Group to a “strong-buy” rating in a report issued on Tuesday,Zacks.com reports.

MOBI has been the subject of a number of other research reports. Wall Street Zen upgraded shares of Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. Bank of America started coverage on shares of Mobia Medical in a research note on Tuesday. They set a “buy” rating and a $16.00 target price for the company. BTIG Research started coverage on shares of Mobia Medical in a research note on Tuesday. They set a “buy” rating and a $19.00 target price for the company. Wolfe Research started coverage on shares of Mobia Medical in a research note on Tuesday. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. started coverage on shares of Mobia Medical in a research note on Tuesday. They set an “overweight” rating and a $15.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $20.25.

Mobia Medical Stock Down 0.4%

Shares of MOBI opened at $13.73 on Tuesday. Mobia Medical has a one year low of $10.19 and a one year high of $14.77. The stock has a market capitalization of $454.26 million, a PE ratio of 66.00 and a beta of 2.84.

Insider Activity at Mobia Medical

In related news, insider Chase C. Leavitt bought 3,000 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $15.00 per share, for a total transaction of $45,000.00. Following the purchase, the insider owned 3,000 shares in the company, valued at $45,000. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dana G. Jr. Mead bought 7,000 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were bought at an average price of $15.00 per share, with a total value of $105,000.00. Following the purchase, the director owned 7,000 shares in the company, valued at $105,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 1,268,332 shares of company stock worth $19,024,980 in the last quarter.